Background and Aims: Pneumonia is a major cause of mortality and morbidity in kidney transplant (KT) recipients. Anuradhapura District has the highest prevalence of chronic kidney disease of unknown origin (CKDu), which is the major cause of CKD in the country.
Teaching Hospital, Anuradhapura, Sri Lanka Background and Aims: Pneumonia is a major cause of mortality and morbidity in kidney transplant (KT) recipients. Anuradhapura District has the highest prevalence of chronic kidney disease of unknown origin (CKDu), which is the major cause of CKD in the country.
Methods: Forty-six recipients (41 males; mean age 43 years) have been followed up for average 17 (range 06-36) months at KT clinic, Teaching Hospital Anuradhapura since 2012. All patients who presented with pneumonia were admitted and managed in high dependency or intensive unit, by multi-disciplinary team including nephrologist, pulmonologist and microbiologist. All patients underwent sputum, blood and urine cultures and all who were intubated had tracheal aspirates or bronchial lavages performed. We accessed their detailed clinic and admission records to identify occurrence of pneumonia during early post-KT period.
Results: Forty-three had CKDu and three had diabetes mellitus leading to CKD in this cohort. Fourteen out of forty-six patients (30%) developed pneumonia during the study period. Majority of them (10 patients; 71%) developed pneumonia within the first year after KT. Bacterial pneumonia with Pseudomonas and coliforms were commonest, while two developed fungal pneumonia and one had smear positive pulmonary tuberculosis. Six (43%) died despite maximum possible care (Table 1) .
All three patients with diabetes developed Post-KT bacterial pneumonia and one of them with resistant coliform growth on sputum culture succumbed to illness. Two patients with cultures showing no growth, were treated with combined antibiotics (to cover Gram negatives, MRSA and anaerobes) and antifungals, but also died. The patient developed tuberculosis did not have past tuberculosis.
Conclusion:
We noted a high incidence (30%) of pneumonia in the early post-KT period in this cohort with predominant CKDu. Three were only three patients with diabetes and all of them developed pneumonia. Pseudomonas and coliforms were the commonest organisms responsible. Early post-KT pneumonia had a high mortality of 43%. His chest X-ray showed a 5-cm irregular mass lesion in the right upper lobe and small nodular densities in bilateral lung fields ( Figure 1A ). Compared with the chest radiograph 5 months before ( Figure 1B) , the largest mass lesion had a rapid growth rate.
Methods: Contrast enhanced chest CT scan revealed a mass lesion at right upper lung field accompanied by multiple nodules in both lung fields ( Figure 1D ). There was mild erythematous change with mucosal swelling and purulent sputum at the bronchial orifice of apical segment of right upper lobe without endobronchial visible lesions under the flexible fiberoptic bronchoscope. The transbronchial biopsy showed chronic inflammatory infiltrates with no evidence of granuloma formation. Immunohistochemical analysis was negative to cytokeratin AE1/AE3, p40, and TTF-1. Special stains of PAS, GMS and AFB were negative for microorganisms ( Figure 1E-H) . On the 5th hospital day, Nocardia species was isolated from bronchial brushing specimen.
Results: After receiving TMP-SMX for 6 days, he developed an acute altered mental status with agitation and lower extremities weakness. The cerebrospinal fluid analysis revealed normal cell counts, glucose and protein, and the culture did not yield any growth of a microorganism. TMP-SMX was changed to ceftriaxone and doripenem on day 15 of the hospitalization. Within 5 days of the discontinuation of TMP-SMX use, he gradually returned to his baseline mental status. At the 2-month follow-up, the radiographic size of initial lesion had significantly decreased in size after treatment ( Figure 1C) .
This case highlights the importance of keeping in mind the possibility of pulmonary nocardiosis in immunocompromised patients and alerting patients about a rare side effect of TMP-SMX. 
